China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency. See ...

Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of capital are costing Europe its biotech edge.

The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance ...

Everything is changing according to technology, and the role of data architects is pivotal in driving innovation while ...

Alnylam Pharmaceuticals Inc. is bringing online a new manufacturing process that will allow it to increase its capacity as ...

The problems cut across the industry as a whole. Many publicly traded biotech companies are now valued at less than the cash ...

Touchstone and Rowley highlight why companies like Eli Lilly, Novo Nordisk, and Genentech are choosing to set up shop in ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax efficient and ...

The Boston biotech has secured $33 million in venture capital and $5 million in NIH funding to advance its once-daily obesity pill.

As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

EY life sciences leader Arda Ural is among those watching and said that China is no longer the land of generics and active pharmaceutical ingredients (APIs) used by the rest of th ...